Vertex Pharma (VRTX) Announces Positive Longer-Term ORKAMBI + KALYDECO Data in CF Progression Modification
Go back to Vertex Pharma (VRTX) Announces Positive Longer-Term ORKAMBI + KALYDECO Data in CF Progression Modification| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 397.93 -2.83 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $400.76 | 52 Week High | $134.71 | |||
| Open | $402.44 | 52 Week Low | $73.31 | |||
| Day High | $403.88 | P/E | N/A | |||
| Day Low | $397.05 | EPS | $-1.98 | |||
| Volume | 78,541 | |||||
